Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage

Kessaris, Nicoletta; Fogarty, Matthew; Iannarelli, Palma; Grist, Matthew; Wegner, Michael; Richardson, William D.
February 2006
Nature Neuroscience;Feb2006, Vol. 9 Issue 2, p173
Academic Journal
The developmental origin of oligodendrocyte progenitors (OLPs) in the forebrain has been controversial. We now show, by Cre-lox fate mapping in transgenic mice, that the first OLPs originate in the medial ganglionic eminence (MGE) and anterior entopeduncular area (AEP) in the ventral forebrain. From there, they populate the entire embryonic telencephalon including the cerebral cortex before being joined by a second wave of OLPs from the lateral and/or caudal ganglionic eminences (LGE and CGE). Finally, a third wave arises within the postnatal cortex. When any one population is destroyed at source by the targeted expression of diphtheria toxin, the remaining cells take over and the mice survive and behave normally, with a normal complement of oligodendrocytes and myelin. Thus, functionally redundant populations of OLPs compete for space in the developing brain. Notably, the embryonic MGE- and AEP-derived population is eliminated during postnatal life, raising questions about the nature and purpose of the competition.


Related Articles

  • Insights into Diphthamide, Key Diphtheria Toxin Effector. Abdel-Fattah, Wael; Scheidt, Viktor; Uthman, Shanow; Stark, Michael J. R.; Schaffrath, Raffael // Toxins;May2013, Vol. 5 Issue 5, p958 

    Diphtheria toxin (DT) inhibits eukaryotic translation elongation factor 2 (eEF2) by ADP-ribosylation in a fashion that requires diphthamide, a modified histidine residue on eEF2. In budding yeast, diphthamide formation involves seven genes, DPH1-DPH7. In an effort to further study diphthamide...

  • Safety evaluation of DT388IL3, a diphtheria toxin/interleukin 3 fusion protein, in the cynomolgus monkey. Cohen, Kimberley; Liu, Tie; Cline, J.; Wagner, Janice; Hall, Philip; Frankel, Arthur // Cancer Immunology, Immunotherapy;Aug2005, Vol. 54 Issue 8, p799 

    We developed a fusion toxin, DT388IL3, consisting of the catalytic and translocation domains of diphtheria toxin (DT388) linked to interleukin 3 (IL3) for the treatment of patients with acute myeloid leukemia (AML). Our goal in this study was to estimate a range for the maximum tolerated dose...

  • Diphtheria in the United States, 1971-81. Chen, Robert T.; Broome, Claire V.; Weinstein, Robert A.; Weaver, Robert A.; Tsai, Theodore F. // American Journal of Public Health;Dec1985, Vol. 75 Issue 12, p1393 

    Abstract: After a decade-long resurgence, including a large cutaneous diphtheria outbreak in Washington State, the diphtheria incidence rate in the United States reached its lowest recorded level ever in 1980--two patients (0.01 case per million). Mortality paralleled the decline in incidence...

  • Recombinant Plants Provide a New Approach to the Production of Bacterial Polysaccharide for Vaccines. Smith, Claire M.; Fry, Stephen C.; Gough, Kevin C.; Patel, Alexandra J. F.; Glenn, Sarah; Goldrick, Marie; Roberts, Ian S.; Whitelam, Garry C.; Andrew, Peter W. // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Bacterial polysaccharides have numerous clinical or industrial uses. Recombinant plants could offer the possibility of producing bacterial polysaccharides on a large scale and free of contaminating bacterial toxins and antigens. We investigated the feasibility of this proposal by cloning and...

  • Diphtheria Is as Deadly as Ever.  // Clinical Pediatrics;Mar1976, Vol. 15 Issue 3, p221 

    Reports on the incidence of diphtheria in the United States where the case-fatality ratio has remained at approximately 10 per cent {10 deaths/100 cases) since 1955. Finding that there is greater risk of death for young (children zero to four years of age) persons with a history of having...

  • Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors. Michl, P.; Gress, T. M. // Current Cancer Drug Targets;Nov2004, Vol. 4 Issue 8, p689 

    Patients with advanced solid tumors frequently relapse and succumb to their metastatic disease after developing resistance to conventional treatment modalities such as chemotherapy and radiotherapy. In these patients, novel strategies of targeting widespread tumors are urgently needed. The...

  • Application of fermentor technology in production of diphtheria toxin. Moghadam, Ahmad Taghavi; Afsharpad, Koroush // Jundishapur Journal of Microbiology;2008, Vol. 1 Issue 1, p24 

    The present study shows the production of diphtheria toxoid in fermentor as compared to old static method of production. With using 45l glass fermentor which has the provision for growth of the organisms under controlled conditions with regard to temperature, pH, aeration and addition of maltose...

  • Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding. Hamaoka, Miki; Chinen, Ichino; Murata, Takuya; Takashima, Seiji; Iwamoto, Ryo; Mekada, Eisuke // Journal of Biochemistry;Jul2010, Vol. 148 Issue 1, p55 

    HB-EGF is a member of the EGF family of growth factors that bind and activate the EGF receptor. HB-EGF is synthesized as a membrane-anchored protein (proHB-EGF), and then proteolytically cleaved, resulting in the mitogenically active soluble form. ProHB-EGF functions as the receptor for the...

  • pH-Triggered Conformational Switching along the Membrane Insertion Pathway of the Diphtheria Toxin T-Domain. Ladokhin, Alexey S. // Toxins;Aug2013, Vol. 5 Issue 8, p1362 

    The translocation (T)-domain plays a key role in the action of diphtheria toxin and is responsible for transferring the catalytic domain across the endosomal membrane into the cytosol in response to acidification. Deciphering the molecular mechanism of pH-dependent refolding and membrane...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics